Inguinal hernia medical therapy: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| Line 29: | Line 29: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
Latest revision as of 22:25, 29 July 2020
|
Inguinal hernia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Inguinal hernia medical therapy On the Web |
|
American Roentgen Ray Society Images of Inguinal hernia medical therapy |
|
Risk calculators and risk factors for Inguinal hernia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
Pharmacologic medical therapies for inguinal hernia include pain reliever, antibiotics, topical medications.
Medical Therapy
- Pharmacologic medical therapies for patients with post-operative repair of inguinal hernia include:[1][2][3][4]
- 1. Pain reliever
- Preferred regimen: Non-steroidal anti-inflammatory drugs(NSAIDs) 400mg PO q12h PRN
- Alternative regimen (1) Gabapentin 300 mg PO q 8h PRN
- Alternative regimen (2): Pregabalin 300 mg PO q 8h PRN
- Alternative regimen (5): Opioids 2-10 mg IV q 2-4h PRN
- Alternative regimen (6): Tramadol 50-100 mg PO q 4-6h PRN
- Alternative regimen (3): Duloxetine 30 mg PO q 24h for 1 week
- Alternative regimen (4): Venlafaxine 75-225 mg PO q 24h for 1 week
- 2. Antibiotics
- Preferred regimen: Cefazolin 2 g IV for 7 days
- Alternative regimen (1): Clindamycin 900 mg q 8h for 7 days
- Alternative regimen (2): Vancomycin 15 mg/kg IV for 7-10 days
- Alternative regimen (3): Ciprofloxacin 400 mg IV for 10 days
- Alternative regimen (4): levofloxacin 500 mg IV for 5 days
- Alternative regimen (5): Aztreonam 2 g IV q 6-8h (not to exceed 8g/day)
- 3. Topical medications
- 1. Pain reliever
References
- ↑ Bjurstrom MF, Nicol AL, Amid PK, Chen DC (2014). "Pain control following inguinal herniorrhaphy: current perspectives". J Pain Res. 7: 277–90. doi:10.2147/JPR.S47005. PMC 4045265. PMID 24920934.
- ↑ Cohen SP, Galvagno SM, Plunkett A, Harris D, Kurihara C, Turabi A, Rehrig S, Buckenmaier CC, Chelly JE (2013). "A multicenter, randomized, controlled study evaluating preventive etanercept on postoperative pain after inguinal hernia repair". Anesth. Analg. 116 (2): 455–62. doi:10.1213/ANE.0b013e318273f71c. PMID 23302973.
- ↑ Derry S, Sven-Rice A, Cole P, Tan T, Moore RA (2013). "Topical capsaicin (high concentration) for chronic neuropathic pain in adults". Cochrane Database Syst Rev (2): CD007393. doi:10.1002/14651858.CD007393.pub3. PMID 23450576.
- ↑ O'Connor AB, Dworkin RH (2009). "Treatment of neuropathic pain: an overview of recent guidelines". Am. J. Med. 122 (10 Suppl): S22–32. doi:10.1016/j.amjmed.2009.04.007. PMID 19801049.